Euglena Co., Ltd. (FRA:8EG)

Market Cap	269.42M -30.3%
Revenue (ttm)	281.76M +7.8%
Net Income	-931.60K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.01 (0.57%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Open	1.890
Previous Close	1.900
Day's Range	1.890 - 1.890
52-Week Range	1.710 - 2.760
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and socia...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 793
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8EG

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error